TLSA

TLSA

USD

Tiziana Life Sciences Ltd. Common Shares

$1.790-0.060 (-3.243%)

Prix en Temps Réel

Healthcare
Biotechnologie
Royaume-Uni

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$1.850

Haut

$1.850

Bas

$1.790

Volume

0.16M

Fondamentaux de l'Entreprise

Capitalisation Boursière

212.7M

Industrie

Biotechnologie

Pays

United Kingdom

Statistiques de Trading

Volume Moyen

0.38M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $0.63Actuel $1.790Haut $2.6

Actualités Connexes

GlobeNewswire

Aquestive Therapeutics Announces Leadership Expansion to Support Growth

Changes strategically aligned to support planned launch of Anaphylm™ (dibutepinephrine) Sublingual Film, if approved by the FDA, and to accelerate the Company's ongoing development initiatives Matthew Davis, M.D.,

Voir plus
Aquestive Therapeutics Announces Leadership Expansion to Support Growth
GlobeNewswire

Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy

BOSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development

Voir plus
Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy